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An alternative treatment is needed to counter the increase in antibiotic resistant pathogens as they evolve to resist different
antibiotics. Bacteriocins are toxic peptides and proteins often produced by lactic acid forming bacteria such as lactobacilli.
Recent research revealed that genomes of urinary isolates of Lactobacillus gasseri S1 and Lactobacillus delbrueckii S9
bacteria encode for several putative bacteriocins. We also discovered that these lactobacilli inhibit the growth of major
uropathogens. The goal of this project is to test whether identified bacteriocin genes are expressed. Primers were designed
and tested that allowed us to access transcription of the bacteriocin genes via reverse transcription PCR. If our analysis
finds bacteriocins capable of inhibiting the uropathogens, these bacteriocins can serve as a possible alternative treatment
for complicated or drug-resistant urinary tract infections.

Materials and Methods
•

Complementary DNA (cDNA) was prepared by
reverse transcription reaction from the total
RNA isolated from lactobacilli strains
Lactobacilli gasseri S1 & Lactobacillus
delbrueckii S9.

Results
•

Four pairs of primers were successful in amplifying the predicted genes of
Enterolysin A and Helveticin J genes (oSL 39 – oSL 48, Table 1) and these
primers were used for initial tests of bacteriocin expression.
Table 1. Primers to amplify predicted bacteriocin genes

•

•

Genomic DNA (gDNA) of S1 and S9 strains were
used for testing the newly designed primers in
polymerase chain reaction (PCR) (Table 1, Fig.
1) using Q5 Polymerase MasterMix

Lactobacillus
Strain
L. gasseri S1

Predicted
Bacteriocin

Primer ID

Sequence

Temperature
Predicted

Temperature
Used

Expected
Product
Size

Helveticin J

oSL 39
oSL 40
oSL 43
oSL 44
oSL 45
oSL 46
oSL 47

CGTAGCAGTTTCTGGATATC

61°C

59°C

203 bp

62°C

59°C

173 bp

62°C

59°C

172 bp

62°C

59°C

194 bp

oSL 48

GATTGTAAAGTAGCCGTTGC

Enterolysin A

PCR program:

L. delbrueckii S9

Helveticin J1
Helveticin J2

98°C - 60 s
98°C - 40 s
55-6°C - 15 s
72°C - 5 s
72°C - 120 s

Fig. 1. PCR Machine

25 cycles

•

cDNA was used to test for expression of
bacteriocin genes while gDNA and RNA were
used as positive and negative controls
respectively (Fig. 7)

•

PCR products were analyzed on 2% agarose gel
with ethidium bromide staining (Fig. 2-3).

GCCCTGTTATGGTTGATGT
CTGTTTTGGCTATTCACCC
CTTGTCGCCTAGCTTGAC
GCAAACTTGGGAATATGCTG
GTTGAGGTAAGCCAAACG
GTGTCGATATCAAAGCACAG

•

PCR from cDNA of S1 strain revealed the expected PCR product; however,
so did the negative control of RNA template as well. This is an indication of
gDNA contamination in the RNA and cDNA preparations.

•

Neither of the three predicted bacteriocin genes in S9 strain were amplified
from cDNA template suggesting no expression of these genes under tested
condition.
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Fig. 7. Analysis of PCR products using Lactobacilli S1 & S9 samples
Fig. 3. Gel Analysis
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Our results confirmed the presence of bacteriocin genes in lactobacillus strains S1 and S9, but did not show strong
expression of these genes. Future study will involve continued PCR testing using DNA samples from different growth stages
of lactobacilli to discover the stages in which bacteriocins are produced.
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